Embleema Awarded $5M Department of Defense Contract. Partners With GRAVL and Aria Diagnostics to Create Global Pathogen Bio Surveillance Infrastructure

Embleema, in partnership with GRAVL and Aria Diagnostics (ARIA), has secured a $5 million Department of Defense (DoD) contract to deploy ANTIDOTE, a pioneering biosecurity platform capable of ...

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Cosmos Health is at a turning point in its journey. We have aligned every business unit around a common goal: creating a global healthcare and life sciences platform that integrates pharmaceuticals, ...

Cosmos Health Inc.: Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion ...

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its ...
TipRanks on MSN

Enanta reports ‘positive’ results from Phase 2b study of zelicapavir

Pharmaceuticals announced positive topline data from RSVHR, a Phase 2b, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of zelicapavir in outpatient adults with ...